Valérie Van Steenbergen (Bareyre Lab) awarded with an Alexander von Humboldt post-doctoral fellowship
November 2020 – Valérie Van Steebergen, from our institute and post-doctoral student in the laboratory of Florence Bareyre has been awarded a 2-years post-doctoral fellowship from the Alexander von Humboldt Foundation. During this time, Valérie will study the role of neuronal activity in the shapping of new circuits following CNS injury. Her work should determine whether and how stimulation of activity in nerve cells can drive functional recovery following CNS injuries. (Read More...)
Martin Kerschensteiner elected to the National Academy of Sciences (Leopoldina)
October 2020 – Martin Kerschensteiner, director of the Institute of Clinical Neuroimmunology, has been elected as a member of the German National Academy of Sciences Leopoldina. The Leopoldina orignated in 1652 and now has 1600 members from almost all branches of sience. The mission of the Leopoldina is to represent the German scientific community internationally and provide policy makers and the public with science-based evidence. Martin Kerschensteiner will join the „Sektion“ Neurosciences (Read More...)
Simone Mader (Meinl Lab) receives funding from Novartis to search for new CNS-reactive antibodies
October 2020 – Simone Mader from our institute will receive 40.000 Euro funding for her Oppenheim-Förderpreis application on the “Characterization of CNS-reactive antibodies in multiple sclerosis and related diseases” after internal validation by Novartis. For this study, Simone Mader will focus on patients with multiple sclerosis or similar diseases who present with optic neuritis. Brain-reactive antibodies and B cells will be investigated using novel methodological approaches, in order to identify target antigens. The identification of such autoantibodies is of high diagnostic and therapeutic relevance.